An Unusual Case of Giant Bullous Disease
<h3>Case Presentation</h3> A 50-year-old African American woman presented to the lung transplant clinic for evaluation after experiencing gradually worsening dyspnea over the preceding 5 years. She had been diagnosed with COPD by another pulmonologist. Since her diagnosis 10 years before presentation, the patient had been on continuous supplemental oxygen therapy at 2 L/min. Her treatment regimen included a once daily combination inhaler (a corticosteroid and an ultra-long-acting ß-adrenoceptor agonist) along with an albuterol inhaler used as needed. The patient's dyspnea limited her ability to walk half a block, and she often required a few minutes to recover after these efforts. Her symptoms were partially alleviated by use of her albuterol inhaler. In addition to dyspnea, the patient reported a nonproductive cough that was exacerbated by activity and relieved by rest. The patient's medical history included OSA requiring positive airway pressure therapy and a hospitalization for respiratory distress due to a COVID-19 infection 12 months before presentation. She had a < 10-pack-year smoking history and childhood exposure to secondhand smoke. She had no known exposure to organic dusts or asbestos.
Authors
- Jonathan Ioanitescu
- Tiana Endicott-Yazdani (ORCID: https://orcid.org/0000-0001-7667-1706)
- Kazuhiro Yoshino
- Susan K. Mathai (ORCID: https://orcid.org/0000-0002-5899-8083)
- Haiying Zhang (ORCID: https://orcid.org/0000-0003-1911-7957)
Institutions
- Baylor University Medical Center (US)
- Texas A&M University (US)
Publication Details
- Journal
- CHEST Pulmonary
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.chpulm.2024.100121
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00